Feasibility and Safety of Transhiatal Approach and D2 Total Gastrectomy after Neoadjuvant Chemotherapy for Adenocarcinoma of the Esophago-Gastric Junction: A Subset Analysis of the COMPASS Trial

Background: It was unclear whether the transhiatal approach and D2 total gastrectomy after neoadjuvant chemotherapy (NAC) for adenocarcinoma of the esophago-gastric (AEG) junction are as feasible and safe as D2 gastrectomy following NAC. Patients and Methods: We clarified the short-term surgical res...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Digestive surgery 2016-01, Vol.33 (5), p.424-430
Hauptverfasser:	Yoshikawa, Takaki, Aoyama, Toru, Tanabe, Kazuaki, Nishikawa, Kazuhiro, Ito, Yuichi, Hayashi, Tsutomu, Cho, Haruhiko, Miyashita, Yumi, Tsuburaya, Akira, Sakamoto, Junichi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - surgery Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Chemotherapy, Adjuvant Cisplatin - administration & dosage Dissection Drug Combinations Esophagogastric Junction - surgery Feasibility Studies Female Gastrectomy - adverse effects Gastrectomy - methods Humans Male Margins of Excision Middle Aged Neoadjuvant Therapy Neoplasm, Residual Original Paper Oxonic Acid - administration & dosage Paclitaxel - administration & dosage Stomach Neoplasms - drug therapy Stomach Neoplasms - surgery Tegafur - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!